PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($) |
Jul. 31, 2026 |
Apr. 30, 2026 |
|---|---|---|
| Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | ||
| Prepaid clinical trial expenses | $ 475,035 | $ 991,850 |
| Prepaid insurance | 174,781 | 41,972 |
| Other prepaid expenses | 13,620 | 19,986 |
| Total prepaid expenses and other current assets | $ 663,436 | $ 1,053,808 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets. No definition available.
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|